A new approach to disease-modifying drug trials in Parkinson's disease
Journal of Clinical Investigation (2013) - Comments
pubmed: 23728166  doi: 10.1172/jci69690  issn: 1558-8238  issn: 0021-9738 

Roger A. Barker, Mark Stacy, Patrik Brundin